ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 102 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $29 | +123.1% | 18 | 0.0% | 0.00% | – |
| Q1 2023 | $13 | +30.0% | 18 | 0.0% | 0.00% | – |
| Q4 2022 | $10 | – | 18 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 18 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 18 | -100.0% | 0.00% | – |
| Q1 2022 | $62,000 | -33.3% | 47,178 | -10.6% | 0.00% | – |
| Q4 2021 | $93,000 | -13.9% | 52,776 | +5.6% | 0.00% | – |
| Q3 2021 | $108,000 | -94.2% | 49,988 | -90.6% | 0.00% | -100.0% |
| Q2 2021 | $1,866,000 | +161.7% | 532,930 | +636.0% | 0.00% | – |
| Q1 2021 | $713,000 | -26.3% | 72,413 | -18.8% | 0.00% | -100.0% |
| Q4 2020 | $967,000 | -91.0% | 89,223 | -91.4% | 0.00% | -85.7% |
| Q3 2020 | $10,721,000 | +1087.3% | 1,040,815 | +2306.3% | 0.01% | +600.0% |
| Q2 2020 | $903,000 | -11.9% | 43,253 | -58.7% | 0.00% | 0.0% |
| Q1 2020 | $1,025,000 | -59.5% | 104,817 | -52.3% | 0.00% | -50.0% |
| Q4 2019 | $2,530,000 | +441.8% | 219,774 | +155.7% | 0.00% | – |
| Q3 2019 | $467,000 | +17.6% | 85,966 | +156.6% | 0.00% | – |
| Q2 2019 | $397,000 | +14.4% | 33,508 | -49.8% | 0.00% | – |
| Q1 2019 | $347,000 | -8.4% | 66,689 | -44.7% | 0.00% | – |
| Q4 2018 | $379,000 | -83.4% | 120,493 | -68.0% | 0.00% | -100.0% |
| Q3 2018 | $2,277,000 | -32.7% | 376,730 | -41.0% | 0.00% | 0.0% |
| Q2 2018 | $3,383,000 | +126.3% | 638,630 | +147.6% | 0.00% | 0.0% |
| Q1 2018 | $1,495,000 | +11.5% | 257,938 | -32.7% | 0.00% | 0.0% |
| Q4 2017 | $1,341,000 | +97.2% | 383,330 | +105.6% | 0.00% | – |
| Q3 2017 | $680,000 | +176.4% | 186,445 | +88.6% | 0.00% | – |
| Q2 2017 | $246,000 | -27.9% | 98,839 | -22.4% | 0.00% | – |
| Q1 2017 | $341,000 | +11.1% | 127,343 | +19.5% | 0.00% | – |
| Q4 2016 | $307,000 | -71.2% | 106,523 | -59.0% | 0.00% | -100.0% |
| Q3 2016 | $1,065,000 | +32.1% | 259,539 | +1.7% | 0.00% | 0.0% |
| Q2 2016 | $806,000 | – | 255,214 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,112,355 | $85,866,000 | 42.72% |
| Versant Venture Management, LLC | 7,003,892 | $146,241,265,000 | 21.01% |
| ACUTA CAPITAL PARTNERS, LLC | 1,746,500 | $36,467,000 | 10.54% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $10,022,000 | 5.33% |
| Ghost Tree Capital, LLC | 900,000 | $18,792,000 | 4.96% |
| RTW INVESTMENTS, LP | 6,790,027 | $141,776,000 | 3.99% |
| RA Capital Management | 7,801,641 | $162,898,000 | 3.17% |
| Avoro Capital Advisors LLC | 7,585,000 | $158,375,000 | 3.13% |
| FRAZIER MANAGEMENT LLC | 1,437,028 | $30,005,000 | 2.64% |
| Soleus Capital Management, L.P. | 218,723 | $4,566,000 | 2.60% |